Today,

postmenopausal women treating osteoporosis

can also reduce the risk of invasive breast cancer

with

one m edicine—EVISTA.

If you're past menopause and treating osteoporosis, now

is the time to talk to your doctor about EVISTA. It's the only

medicine for postmenopausal women with osteoporosis

that has also been proven to reduce the risk of invasive

breast cancer.

Ask your doctor if EVISTA is right for you. He or she can

explain all your risk factors for invasive breast cancer and

why it's important to continue regular screenings.

Here are some important things you should know about

EVISTA: Prescription EVISTA is for women past menopause

only. Talk to your doctor about all your medical conditions.

EVISTA increases the risk of blood clots and should not be

used by women who have or have had blood clots in the

legs, lungs or eyes. Seek care immediately if you have leg

pain or warmth, swelling of the legs, hands or feet, chest

pain, shortness of breath or a sudden vision change. EVISTA

may increase the risk of dying from stroke in women at high

risk for heart disease or stroke.

Do not use EVISTA if you are

pregnant, nursing or may become pregnant, as it may cause

fetal harm. Women with liver or kidney disease should use

EVISTA with caution. EVISTA should not be taken with

estrogens. Side effects may include hot flashes, leg cramps

and swelling. Results may vary. You are encouraged to

report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

If you're already treating osteoporosis and want to know

more about EVISTA, call

1

-

8 8 8

-

7 7

-EVISTA

or visit

evista.com.

Ask your doctor about EVISTA, one medicine that does both.

EVISTA does not treat breast cancer, prevent it from returning or reduce the risk of all forms of breast cancer.

€ VISTA

raloxifene HCl

One medicine that does both.

If you need assistance with prescription costs, help

may be available. Visit www.ppaoc.org or call

1

-

888

-

4

PPA-NOW

.

Please see back page for additional information about EVISTA.

RA-52319